Member Info for dunk1973

Officially it is H2.

So any time between now and Dec.

So approx 71k treatments per month?

Top trader- your theory is incorrect.
Trials have always took years to progress.

In fact during covid the trials are progressing quicker than they normally would.

Golden rule of investing.

Never borrow to buy shares.

My holding would allow me to retire at age 48 if I hit my target of £10.

To me that would be life changing.

Long way from this investment being safe but very encouraging. Poly would not invest £35m without being very confident. Serious risk analysis and due diligence has been done by them.

Syn00gold - what was the figure SSH confirmed for the start volume on immediate approval?

I cannot see that figure from the tweet.

Nice that SSH has confirmed start volume on immediate approval that will be available.

Thanks very much for explaining.

Can anyone explain what this means from the RNS.

RD can you expand on what you mean by.

4. Details old payments is a secret but everyone is happy

testing of contacts is not covered by this authorisation”

So what would the remaining Innova tests be used on if not for daily testing.

What a silly post based on the evidence presented about Activ 2.

Sang I am sure I saw a post from you saying you were invested in Tils or were invested.

Please confirm.

Sang can I ask why you invested then if all the above is true.

You paint a very dull picture for Tils to advance further with its pipeline.

Tils seem to be trying everything to get the price higher.

1. Posts good covid data results although a small data set.

2. Announces a Phase 2 covid trial to start soon.

3. Other positive pipeline plans updated.

4. Investor presentations galore.

And still the price is sub 60p.

What will it take to get the price over £1 and then.£2?

I personally believe this is it until Tils move onto a Phase 3 trial. Until there is a sniff of commercialisation this price is going to drift further or see saw between 50p and 70p. Such a shame with all the promises made. This was pumped so much last year by the company and a select few on here, facebook and twitter. Looks like that pumping has damaged the integrity of the company and many don't trust it anymore to rise just on it's own back.

PR is none existent with Tils.

This was always going to IPO with additional shares so not sure why people are suprosed by this.

I believe GC mentioned a listing price of 60p. If that happens I'll be happy with that. Any more and it's a big bonus.

"...and we cannot conclude that nasal Foralumab has a beneficial effect in COVID-19 until larger studies are performed"

This was always going to be the case in a Phase 1 trial with only 39 patients. Not unexpected at all for such results.

Elsol excellently explained in simple terms.

"The options that have been exercised were due to expire in September 2021. Certain of the new ordinary shares have been sold, at a price of 140p, to meet the tax and subscription costs associated with the exercise, with the remaining shares being retained by the directors.'

Duffer did you read the RNS properly?